Table 1 Baseline characteristics of PCHD patients according to the presence/absence of END

Demographics

Age, median (IQR)

71.11 ± 15.72

67.70 ± 13.82

0.365

Men, n (%)

15 (55.6%)

58 (71.6%)

0.123

Medical history

Hypertension, n (%)

15 (55.6%)

50 (61.7%)

0.570

Diabetes mellitus, n (%)

20 (74.1%)

43 (53.1%)

0.055

Atrial fibrillation, n (%)

16 (59.3%)

36 (44.4%)

0.182

Current smoking, n (%)

4 (14.8%)

19 (23.5%)

0.342

NHISS score before MT

19.00 (15.00–22.00)

16.00 (12.00–20.00)

0.014^*

OTR, median (IQR)

325.00 (254.00-366.00)

294.00 (201.50-461.50)

0.731

DTP, median (IQR)

117.00 (75.00-152.00)

88.00 (78.00-125.50)

0.120

Thrombolysis, n (%)

12 (44.4%)

25 (30.9%)

0.198

Stroke subtype, n (%)

0.461

LAA

10 (37.0%)

42 (51.8%)

CE

13 (48.1%)

31 (38.3%)

SOE

1 (3.7%)

3 (3.7%)

SUE

3 (11.1%)

5 (6.2%)

TICI, n (%)

0.701

0

0 (0.0%)

2(2.5%)

1

1 (3.7%)

2 (2.5%)

2a

3 (11.1%)

5(6.2%)

2b

8 (29.6%)

20 (24.7%)

3

15 (55.6%)

52 (64.2%)

Low density on CT after MT, n (%)

0.027^*

Without low density on CT

7 (25.9%)

28 (34.6%)

Low density on CT < 1/3 vascular territory

11 (40.7%)

44 (54.3%)

Low density on CT > 1/3 vascular territory

9 (33.3%)^*

9 (11.1%)

Residual vascular condition, n (%)

0.723

Without stenosis

11 (40.7%)

29 (35.8%)

Stenosis

16 (59.3%)

48 (59.3%)

Occlusion

0 (0.0%)

4 (4.9%)

MT procedure, n (%)

0.362

SR

0 (0.0%)

6 (7.4%)

CA

0 (0.0%)

3 (3.7%)

Combined SR and CA

27 (100%)

72 (81.9%)

Initial occlusion site, n (%)

0.673

ICA

11 (40.7%)

30 (37.0%)

M1

14 (51.9%)

42 (51.9%)

M2

0 (0.0%)

5 (6.2%)

Tandem

2 (7.4%)

4 (4.9%)

Stent implantation, n (%)

3 (11.1%)

1 (1.2%)

0.078

Antithrombotic therapy, n (%)

6 (22.2%)

45 (55.6%)

0.003^*